{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:15:51Z","timestamp":1793376951184,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-127236OB-100"],"award-info":[{"award-number":["PID2021-127236OB-100"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00594"],"award-info":[{"award-number":["PI22\/00594"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-024-01549-x","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T04:02:11Z","timestamp":1723608131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Plasma lipidomics in early APP\/PS1 female mouse model and its relationship with brain: Is it affected by the estrous cycle?"],"prefix":"10.1186","volume":"16","author":[{"given":"Laura","family":"Ferr\u00e9-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Balaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artemis","family":"Ftara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lloret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Ch\u00e1fer-Peric\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"1549_CR1","first-page":"149","volume":"70","author":"J Durmugier","year":"2020","unstructured":"Durmugier J, Sabia S. Epidemiology of Alzheimer\u2019s disease: latest trends. Rev Prat. 2020;70:149\u201351.","journal-title":"Rev Prat"},{"key":"1549_CR2","unstructured":"World Health Organization. Dementia. 2022 [cited 2022 Oct 19]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia"},{"key":"1549_CR3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/JAD-180141","volume":"64","author":"CR Beam","year":"2018","unstructured":"Beam CR, Kaneshiro C, Jang JY, Reynolds CA, Pedersen NL, Gatz M. Differences between women and men in incidence rates of dementia and Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2018;64:1077\u201383. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-180141.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1549_CR4","doi-asserted-by":"publisher","first-page":"S527","DOI":"10.3233\/JAD-2010-100501","volume":"20","author":"J Vi\u00f1a","year":"2010","unstructured":"Vi\u00f1a J, Lloret A. Why women have more Alzheimer\u2019s disease than men: gender and mitochondrial toxicity of amyloid-\u03b2 peptide. Zhu X, Beal MF, Wang X, Perry G, Smith MA, editors. J Alzheimer\u2019s Dis. 2010;20:S527-33. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-2010-100501.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1549_CR5","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jalz.2018.08.003","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM, Ferretti MT, Iulita MF, Hayden K, Khachaturian AS. Sex and gender in Alzheimer\u2019s disease \u2013 Does it matter? Alzheimer\u2019s Dement. 2018;14:1101\u20133. Available from: https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1016\/j.jalz.2018.08.003.","journal-title":"Alzheimer\u2019s Dement."},{"key":"1549_CR6","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2021;17:327\u2013406.","DOI":"10.1002\/alz.12328"},{"key":"1549_CR7","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1212\/WNL.0000000000004425","volume":"89","author":"L Mosconi","year":"2017","unstructured":"Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, et al. Sex differences in Alzheimer risk. Neurology. 2017;89:1382\u201390. Available from: https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000004425.","journal-title":"Neurology."},{"key":"1549_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.maturitas.2014.05.008","volume":"79","author":"WA Rocca","year":"2014","unstructured":"Rocca WA, Mielke MM, Vemuri P, Miller VM. Sex and gender differences in the causes of dementia: A narrative review. Maturitas. 2014;79:196\u2013201. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512214001601.","journal-title":"Maturitas."},{"key":"1549_CR9","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.cmet.2017.04.033","volume":"25","author":"F Mauvais-Jarvis","year":"2017","unstructured":"Mauvais-Jarvis F, Arnold AP, Reue K. A guide for the design of pre-clinical studies on sex differences in metabolism. Cell Metab. 2017;25:1216\u201330. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413117302863.","journal-title":"Cell Metab."},{"key":"1549_CR10","doi-asserted-by":"crossref","unstructured":"Castro-Aldrete L, Moser MV, Putignano G, Ferretti MT, Schumacher Dimech A, Santuccione Chadha A. Sex and gender considerations in Alzheimer\u2019s disease: The Women\u2019s Brain Project contribution. Front Aging Neurosci. 2023;15. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1105620\/full","DOI":"10.3389\/fnagi.2023.1105620"},{"key":"1549_CR11","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1111\/bph.14539","volume":"176","author":"NA Karp","year":"2019","unstructured":"Karp NA, Reavey N. Sex bias in preclinical research and an exploration of how to change the status quo. Br J Pharmacol. 2019;176:4107\u201318. Available from: https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.14539.","journal-title":"Br J Pharmacol."},{"key":"1549_CR12","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s11095-021-03098-6","volume":"38","author":"EM Rhea","year":"2021","unstructured":"Rhea EM, Banks WA. Interactions of Lipids, Lipoproteins, and Apolipoproteins with the Blood-Brain Barrier. Pharm Res. 2021;38:1469\u201375. Available from: https:\/\/link.springer.com\/10.1007\/s11095-021-03098-6.","journal-title":"Pharm Res."},{"key":"1549_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3727\/000000007783464731","volume":"16","author":"BS Desai","year":"2007","unstructured":"Desai BS, Monahan AJ, Carvey PM, Hendey B. Blood-brain barrier pathology in Alzheimer\u2019s and Parkinson\u2019s disease: implications for drug therapy. Cell Transplant. 2007;16:285\u201399. Available from: http:\/\/journals.sagepub.com\/doi\/10.3727\/000000007783464731.","journal-title":"Cell Transplant."},{"key":"1549_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.plipres.2009.10.004","volume":"49","author":"R Takechi","year":"2010","unstructured":"Takechi R, Galloway S, Pallebage-Gamarallage MMS, Lam V, Mamo JCL. Dietary fats, cerebrovasculature integrity and Alzheimer\u2019s disease risk. Prog Lipid Res. 2010;49:159\u201370. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782709000563.","journal-title":"Prog Lipid Res."},{"key":"1549_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3233\/JAD-160907","volume":"57","author":"FT Hane","year":"2017","unstructured":"Hane FT, Robinson M, Lee BY, Bai O, Leonenko Z, Albert MS. Recent progress in Alzheimer\u2019s disease research, part 3: diagnosis and treatment. J Alzheimer\u2019s Dis. 2017;57:645\u201365. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-160907.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1549_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/1567205016666190517121140","volume":"16","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Far\u00edas GA, Fuentes P, Navarrete LP. Biomarkers for Alzheimer\u2019s Disease. Curr Alzheimer Res. 2019;16:518\u201328. Available from: https:\/\/www.eurekaselect.com\/172184\/article.","journal-title":"Curr Alzheimer Res."},{"key":"1549_CR17","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/ijms21041505","volume":"21","author":"Y-C Kao","year":"2020","unstructured":"Kao Y-C, Ho P-C, Tu Y-K, Jou I-M, Tsai K-J. Lipids and Alzheimer\u2019s Disease. Int J Mol Sci. 2020;21:1505. Available from: https:\/\/www.mdpi.com\/1422-0067\/21\/4\/1505.","journal-title":"Int J Mol Sci."},{"key":"1549_CR18","doi-asserted-by":"crossref","unstructured":"Zhang L, Li L, Meng F, Yu J, He F, Lin Y, et al. Serum metabolites differentiate amnestic mild cognitive impairment from healthy controls and predict early Alzheimer\u2019s disease via untargeted lipidomics analysis. Front Neurol. 2021;12. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.704582\/full","DOI":"10.3389\/fneur.2021.704582"},{"key":"1549_CR19","doi-asserted-by":"crossref","unstructured":"Agarwal M, Khan S. Plasma lipids as biomarkers for Alzheimer\u2019s disease: a systematic review. Cureus. 2020; Available from: https:\/\/www.cureus.com\/articles\/44978-plasma-lipids-as-biomarkers-for-alzheimers-disease-a-systematic-review","DOI":"10.7759\/cureus.12008"},{"key":"1549_CR20","doi-asserted-by":"crossref","unstructured":"Chew H, Solomon VA, Fonteh AN. Involvement of Lipids in Alzheimer\u2019s Disease Pathology and Potential Therapies. Front Physiol. 2020;11. https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2020.00598\/full","DOI":"10.3389\/fphys.2020.00598"},{"key":"1549_CR21","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz C, Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol. 2014;88:640\u201351. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295213008083.","journal-title":"Biochem Pharmacol."},{"key":"1549_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41398-021-01362-2","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Thalamuthu A, Mather KA, Crawford J, Ulanova M, Wong MWK, et al. Plasma lipidome is dysregulated in Alzheimer\u2019s disease and is associated with disease risk genes. Transl Psychiatry. 2021;11:344. Available from: https:\/\/www.nature.com\/articles\/s41398-021-01362-2.","journal-title":"Transl Psychiatry."},{"key":"1549_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jalz.2016.08.003","volume":"13","author":"P Proitsi","year":"2017","unstructured":"Proitsi P, Kim M, Whiley L, Simmons A, Sattlecker M, Velayudhan L, et al. Association of blood lipids with Alzheimer\u2019s disease: A comprehensive lipidomics analysis. Alzheimer\u2019s Dement. 2017;13:140\u201351. Available from: https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1016\/j.jalz.2016.08.003.","journal-title":"Alzheimer\u2019s Dement."},{"key":"1549_CR24","doi-asserted-by":"publisher","first-page":"101223","DOI":"10.1016\/j.plipres.2023.101223","volume":"90","author":"L Ferr\u00e9-Gonz\u00e1lez","year":"2023","unstructured":"Ferr\u00e9-Gonz\u00e1lez L, Lloret A, Ch\u00e1fer-Peric\u00e1s C. Systematic review of brain and blood lipidomics in Alzheimer\u2019s disease mouse models. Prog Lipid Res. 2023;90:101223. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782723000139.","journal-title":"Prog Lipid Res."},{"key":"1549_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JAD-160925","volume":"60","author":"MM Mielke","year":"2017","unstructured":"Mielke MM, Haughey NJ, Han D, An Y, Bandaru VVR, Lyketsos CG, et al. The association between plasma ceramides and sphingomyelins and risk of Alzheimer\u2019s disease differs by sex and APOE in the Baltimore longitudinal study of aging. Mielke M, Martinez P, editors. J Alzheimer\u2019s Dis. 2017;60:819\u201328. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-160925.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1549_CR26","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jalz.2017.01.008","volume":"13","author":"MW Wong","year":"2017","unstructured":"Wong MW, Braidy N, Poljak A, Pickford R, Thambisetty M, Sachdev PS. Dysregulation of lipids in Alzheimer\u2019s disease and their role as potential biomarkers. Alzheimer\u2019s Dement. 2017;13:810\u201327. Available from: https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1016\/j.jalz.2017.01.008.","journal-title":"Alzheimer\u2019s Dement."},{"key":"1549_CR27","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci. 2004;101:2070\u20135. Available from: https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.0305799101.","journal-title":"Proc Natl Acad Sci."},{"key":"1549_CR28","doi-asserted-by":"crossref","unstructured":"Li W, Zhou Y, Luo Z, Tang R, Sun Y, He Q, et al. Lipidomic markers for the prediction of progression from mild cognitive impairment to Alzheimer\u2019s disease. FASEB J. 2023;37. Available from: https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.202201584RR","DOI":"10.1096\/fj.202201584RR"},{"key":"1549_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: evidence for augmentation of a 42-specific \u03b3 secretase. Hum Mol Genet. 2004;13:159\u201370. Available from: https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddh019.","journal-title":"Hum Mol Genet."},{"key":"1549_CR30","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.neurobiolaging.2008.08.005","volume":"31","author":"A Volianskis","year":"2010","unstructured":"Volianskis A, K\u00f8stner R, M\u00f8lgaard M, Hass S, Jensen MS. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe\/PS1\u0394E9-deleted transgenic mice model of \u03b2-amyloidosis. Neurobiol Aging. 2010;31:1173\u201387. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458008002844.","journal-title":"Neurobiol Aging."},{"key":"1549_CR31","doi-asserted-by":"crossref","unstructured":"McLean AC, Valenzuela N, Fai S, Bennett SAL. Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification. J Vis Exp. 2012; Available from: https:\/\/app.jove.com\/t\/4389","DOI":"10.3791\/4389"},{"key":"1549_CR32","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41598-024-51463-3","volume":"14","author":"L Ferr\u00e9-Gonz\u00e1lez","year":"2024","unstructured":"Ferr\u00e9-Gonz\u00e1lez L, Balaguer \u00c1, Roca M, Ftara A, Lloret A, Ch\u00e1fer-Peric\u00e1s C. Brain areas lipidomics in female transgenic mouse model of Alzheimer\u2019s disease. Sci Rep. 2024;14:870. Available from: https:\/\/www.nature.com\/articles\/s41598-024-51463-3.","journal-title":"Sci Rep."},{"key":"1549_CR33","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1093\/bioinformatics\/btac581","volume":"38","author":"MI Alcoriza-Balaguer","year":"2022","unstructured":"Alcoriza-Balaguer MI, Garc\u00eda-Ca\u00f1averas JC, Ripoll-Esteve FJ, Roca M, Lahoz A. LipidMS 3.0: an R-package and a web-based tool for LC-MS\/MS data processing and lipid annotation. Borgwardt K, editor. Bioinformatics. 2022;38:4826\u20138. Available from: https:\/\/academic.oup.com\/bioinformatics\/article\/38\/20\/4826\/6675453.","journal-title":"Bioinformatics."},{"key":"1549_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0844562118786647","volume":"51","author":"FI Mowbray","year":"2019","unstructured":"Mowbray FI, Fox-Wasylyshyn SM, El-Masri MM. Univariate outliers: a conceptual overview for the nurse researcher. Can J Nurs Res. 2019;51:31\u20137. Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/0844562118786647.","journal-title":"Can J Nurs Res."},{"key":"1549_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40738-020-00074-3","volume":"6","author":"AF Ajayi","year":"2020","unstructured":"Ajayi AF, Akhigbe RE. Staging of the estrous cycle and induction of estrus in experimental rodents: an update. Fertil Res Pract. 2020;6:5. Available from: https:\/\/fertilityresearchandpractice.biomedcentral.com\/articles\/10.1186\/s40738-020-00074-3.","journal-title":"Fertil Res Pract."},{"key":"1549_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1476-511X-12-68","volume":"12","author":"Y Tajima","year":"2013","unstructured":"Tajima Y, Ishikawa M, Maekawa K, Murayama M, Senoo Y, Nishimaki-Mogami T, et al. Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein\/tau for Alzheimer\u2019s disease. Lipids Health Dis. 2013;12:68. Available from: https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-12-68.","journal-title":"Lipids Health Dis."},{"key":"1549_CR37","doi-asserted-by":"publisher","first-page":"e0225392","DOI":"10.1371\/journal.pone.0225392","volume":"15","author":"Y Shang","year":"2020","unstructured":"Shang Y, Mishra A, Wang T, Wang Y, Desai M, Chen S, et al. Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice. Reddy H, editor. PLoS One. 2020;15:e0225392. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0225392.","journal-title":"PLoS One."},{"key":"1549_CR38","doi-asserted-by":"publisher","first-page":"964","DOI":"10.18632\/aging.101203","volume":"9","author":"L Abdullah","year":"2017","unstructured":"Abdullah L, Evans JE, Emmerich T, Crynen G, Shackleton B, Keegan AP, et al. APOE \u03b54 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical mild cognitive impairment\/Alzheimer\u2019s disease. Aging (Albany NY). 2017;9:964\u201385. Available from: https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101203.","journal-title":"Aging (Albany NY)."},{"key":"1549_CR39","doi-asserted-by":"publisher","first-page":"14509","DOI":"10.1038\/s41598-020-71510-z","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang X, Liu W, Zan J, Wu C, Tan W. Untargeted lipidomics reveals progression of early Alzheimer\u2019s disease in APP\/PS1 transgenic mice. Sci Rep. 2020;10:14509. Available from: https:\/\/www.nature.com\/articles\/s41598-020-71510-z.","journal-title":"Sci Rep."},{"key":"1549_CR40","doi-asserted-by":"crossref","unstructured":"den Hoedt S, Crivelli SM, Leijten FPJ, Losen M, Stevens JAA, Man\u00e9-Damas M, et al. Effects of sex, age, and apolipoprotein E genotype on brain ceramides and sphingosine-1-phosphate in Alzheimer\u2019s disease and control mice. Front Aging Neurosci. 2021;13. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.765252\/full","DOI":"10.3389\/fnagi.2021.765252"},{"key":"1549_CR41","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/1028415X.2017.1321813","volume":"21","author":"S Canhada","year":"2018","unstructured":"Canhada S, Castro K, Perry IS, Luft VC. Omega-3 fatty acids\u2019 supplementation in Alzheimer\u2019s disease: A systematic review. Nutr Neurosci. 2018;21:529\u201338. Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1028415X.2017.1321813.","journal-title":"Nutr Neurosci."},{"key":"1549_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3233\/JAD-2012-110629","volume":"29","author":"SC Cunnane","year":"2012","unstructured":"Cunnane SC, Schneider JA, Tangney C, Tremblay-Mercier J, Fortier M, Bennett DA, et al. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2012;29:691\u20137. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-2012-110629.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1549_CR43","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.neurobiolaging.2010.09.013","volume":"33","author":"D-C Wang","year":"2012","unstructured":"Wang D-C, Sun C-H, Liu L-Y, Sun X-H, Jin X-W, Song W-L, et al. Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33:1057\u201366. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458010003933.","journal-title":"Neurobiol Aging."},{"key":"1549_CR44","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","volume":"290","author":"F Yin","year":"2023","unstructured":"Yin F. Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J. 2023;290:1420\u201353. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/febs.16344.","journal-title":"FEBS J."},{"key":"1549_CR45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.06.049","volume":"332","author":"J Wu","year":"2016","unstructured":"Wu J, Fu B, Lei H, Tang H, Wang Y. Gender differences of peripheral plasma and liver metabolic profiling in APP\/PS1 transgenic AD mice. Neuroscience. 2016;332:160\u20139. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452216302883.","journal-title":"Neuroscience."},{"key":"1549_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuroscience.2020.01.005","volume":"430","author":"B Zeng","year":"2020","unstructured":"Zeng B, Zhao G, Liu HL. The differential effect of treadmill exercise intensity on hippocampal soluble A\u03b2 and lipid metabolism in APP\/PS1 mice. Neuroscience. 2020;430:73\u201381. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645222030018X.","journal-title":"Neuroscience."},{"key":"1549_CR47","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/jnr.21268","volume":"85","author":"AA Farooqui","year":"2007","unstructured":"Farooqui AA, Horrocks LA, Farooqui T. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide. J Neurosci Res. 2007;85:1834\u201350. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jnr.21268.","journal-title":"J Neurosci Res."},{"key":"1549_CR48","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.bbalip.2012.08.016","volume":"1831","author":"JE Vance","year":"2013","unstructured":"Vance JE, Tasseva G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim Biophys Acta - Mol Cell Biol Lipids. 2013;1831:543\u201354. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198112001874.","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids."},{"key":"1549_CR49","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neuroscience.2018.11.031","volume":"397","author":"X Pan","year":"2019","unstructured":"Pan X, Green BD. Temporal Effects of Neuron-specific beta-secretase 1 (BACE1) Knock-in on the Mouse Brain Metabolome: Implications for Alzheimer\u2019s Disease. Neuroscience. 2019;397:138\u201346. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452218307644.","journal-title":"Neuroscience."},{"key":"1549_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jpba.2014.10.009","volume":"102","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL. Metabolomic screening of regional brain alterations in the APP\/PS1 transgenic model of Alzheimer\u2019s disease by direct infusion mass spectrometry. J Pharm Biomed Anal. 2015;102:425\u201335. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708514005007.","journal-title":"J Pharm Biomed Anal."},{"key":"1549_CR51","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3233\/JAD-215084","volume":"85","author":"M Khorani","year":"2022","unstructured":"Khorani M, Bobe G, Matthews DG, Magana AA, Caruso M, Gray NE, et al. The impact of the hAPP695SW transgene and associated Amyloid-\u03b2 accumulation on murine hippocampal biochemical pathways. J Alzheimer\u2019s Dis. 2022;85:1601\u201319. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-215084.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1549_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biochi.2015.01.005","volume":"110","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL. Deciphering metabolic abnormalities associated with Alzheimer\u2019s disease in the APP\/PS1 mouse model using integrated metabolomic approaches. Biochimie. 2015;110:119\u201328. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908415000103.","journal-title":"Biochimie."},{"key":"1549_CR53","doi-asserted-by":"publisher","first-page":"339337","DOI":"10.1016\/j.aca.2021.339337","volume":"1192","author":"Y Chen","year":"2022","unstructured":"Chen Y, Hu D, Zhao L, Tang W, Li B. Unraveling metabolic alterations in transgenic mouse model of Alzheimer\u2019s disease using MALDI MS imaging with 4-aminocinnoline-3-carboxamide matrix. Anal Chim Acta. 2022;1192:339337. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267021011636.","journal-title":"Anal Chim Acta."},{"key":"1549_CR54","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","volume":"290","author":"F Yin","year":"2023","unstructured":"Yin F. Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J. 2023;290:1420\u201353. Available from: https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1111\/febs.16344.","journal-title":"FEBS J."},{"key":"1549_CR55","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/00005072-199907000-00008","volume":"58","author":"Z Guan","year":"1999","unstructured":"Guan Z, Wang Y, Cairns NJ, Lantos PL, Dallner G, Sindelar PJ. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol. 1999;58:740\u20137. Available from: https:\/\/academic.oup.com\/jnen\/article-lookup\/doi\/10.1097\/00005072-199907000-00008.","journal-title":"J Neuropathol Exp Neurol."},{"key":"1549_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijms.2018.08.010","volume":"434","author":"N-N Zhao","year":"2018","unstructured":"Zhao N-N, Sun Y-F, Zong L, Liu S, Song F-R, Liu Z-Q, et al. Serum lipidomics study of Ding-Zhi-Xiao-Wan effect on Alzheimer\u2019s disease using online liquid extraction surface analysis coupled to direct infusion mass spectrometry. Int J Mass Spectrom. 2018;434:29\u201336. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1387380618301623.","journal-title":"Int J Mass Spectrom."},{"key":"1549_CR57","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00125-016-3960-1","volume":"59","author":"K Pluci\u0144ska","year":"2016","unstructured":"Pluci\u0144ska K, Dekeryte R, Koss D, Shearer K, Mody N, Whitfield PD, et al. Neuronal human BACE1 knockin induces systemic diabetes in mice. Diabetologia. 2016;59:1513\u201323. Available from: http:\/\/link.springer.com\/10.1007\/s00125-016-3960-1.","journal-title":"Diabetologia."},{"key":"1549_CR58","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3233\/JAD-171036","volume":"62","author":"F Dorninger","year":"2018","unstructured":"Dorninger F, Moser AB, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, et al. Alterations in the plasma levels of specific choline phospholipids in Alzheimer\u2019s disease mimic accelerated aging. J Alzheimer\u2019s Dis. 2018;62:841\u201354. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-171036.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1549_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-019-1436-1","volume":"16","author":"NM de Wit","year":"2019","unstructured":"de Wit NM, den Hoedt S, Martinez-Martinez P, Rozemuller AJ, Mulder MT, de Vries HE. Astrocytic ceramide as possible indicator of neuroinflammation. J Neuroinflammation. 2019;16:48. Available from: https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1436-1.","journal-title":"J Neuroinflammation."},{"key":"1549_CR60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.nbd.2014.01.010","volume":"65","author":"M Panchal","year":"2014","unstructured":"Panchal M, Gaudin M, Lazar AN, Salvati E, Rivals I, Ayciriex S, et al. Ceramides and sphingomyelinases in senile plaques. Neurobiol Dis. 2014;65:193\u2013201. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114000242.","journal-title":"Neurobiol Dis."},{"key":"1549_CR61","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","volume":"79","author":"MM Mielke","year":"2012","unstructured":"Mielke MM, Bandaru VVR, Haughey NJ, Xia J, Fried LP, Yasar S, et al. Serum ceramides increase the risk of Alzheimer disease. Neurology. 2012;79:633\u201341. Available from: https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e318264e380.","journal-title":"Neurology."},{"key":"1549_CR62","doi-asserted-by":"crossref","unstructured":"van Kruining D, Losen M, Crivelli SM, de Jong JJA, Jansen JFA, Backes WH, et al. Plasma ceramides relate to mild cognitive impairment in middle\u2010aged men: The Maastricht Study. Alzheimer\u2019s Dement Diagnosis, Assess Dis Monit. 2023;15. https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1002\/dad2.12459","DOI":"10.1002\/dad2.12459"},{"key":"1549_CR63","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.3390\/biomedicines9121812","volume":"9","author":"C Pe\u00f1a-Bautista","year":"2021","unstructured":"Pe\u00f1a-Bautista C, \u00c1lvarez-S\u00e1nchez L, Ca\u00f1ada-Mart\u00ednez AJ, Baquero M, Ch\u00e1fer-Peric\u00e1s C. Epigenomics and lipidomics integration in Alzheimer disease: pathways involved in early stages. Biomedicines. 2021;9:1812. Available from: https:\/\/www.mdpi.com\/2227-9059\/9\/12\/1812.","journal-title":"Biomedicines."},{"key":"1549_CR64","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3233\/JAD-201504","volume":"85","author":"F Sakr","year":"2022","unstructured":"Sakr F, Dyrba M, Br\u00e4uer A, Teipel S. Association of lipidomics signatures in blood with clinical progression in preclinical and prodromal Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2022;85:1115\u201327. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-201504.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1549_CR65","doi-asserted-by":"crossref","unstructured":"Ma Y, Shen X, Xu W, Huang Y, Li H, Tan L, et al. A panel of blood lipids associated with cognitive performance, brain atrophy, and Alzheimer\u2019s diagnosis: A longitudinal study of elders without dementia. Alzheimer\u2019s Dement Diagnosis, Assess Dis Monit. 2020;12. https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dad2.12041","DOI":"10.1002\/dad2.12041"},{"key":"1549_CR66","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-170035","volume":"59","author":"S Anand","year":"2017","unstructured":"Anand S, Barnes JM, Young SA, Garcia DM, Tolley HD, Kauwe JSK, et al. Discovery and confirmation of diagnostic serum lipid biomarkers for Alzheimer\u2019s disease using direct infusion mass spectrometry. J Alzheimers Dis. 2017;59:277\u201390. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28598845.","journal-title":"J Alzheimers Dis."},{"key":"1549_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-021-00814-7","volume":"13","author":"C Clark","year":"2021","unstructured":"Clark C, Dayon L, Masoodi M, Bowman GL, Popp J. An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13:71. Available from: https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00814-7.","journal-title":"Alzheimers Res Ther."},{"key":"1549_CR68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neurobiolaging.2015.11.014","volume":"38","author":"X Pan","year":"2016","unstructured":"Pan X, Nasaruddin MB, Elliott CT, McGuinness B, Passmore AP, Kehoe PG, et al. Alzheimer\u2019s disease\u2013like pathology has transient effects on the brain and blood metabolome. Neurobiol Aging. 2016;38:151\u201363. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015005813.","journal-title":"Neurobiol Aging."},{"key":"1549_CR69","doi-asserted-by":"publisher","first-page":"135401","DOI":"10.1016\/j.neulet.2020.135401","volume":"738","author":"Y-R Bai","year":"2020","unstructured":"Bai Y-R, Wang Y-Y, Meng D-L, Shi Z-L, Song X-F, Yang Z-Z, et al. Alterations of fatty acid composition and metabolism in APP\/PS1 transgenic mice. Neurosci Lett. 2020;738:135401. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394020306716.","journal-title":"Neurosci Lett."},{"key":"1549_CR70","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-020-02152-8","volume":"140","author":"TG Demarest","year":"2020","unstructured":"Demarest TG, Varma VR, Estrada D, Babbar M, Basu S, Mahajan UV, et al. Biological sex and DNA repair deficiency drive Alzheimer\u2019s disease via systemic metabolic remodeling and brain mitochondrial dysfunction. Acta Neuropathol. 2020;140:25\u201347. Available from: https:\/\/link.springer.com\/10.1007\/s00401-020-02152-8.","journal-title":"Acta Neuropathol."},{"key":"1549_CR71","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.stem.2015.08.001","volume":"17","author":"LK Hamilton","year":"2015","unstructured":"Hamilton LK, Dufresne M, Jopp\u00e9 SE, Petryszyn S, Aumont A, Calon F, et al. Aberrant lipid metabolism in the forebrain niche suppresses adult neural stem cell proliferation in an animal model of Alzheimer\u2019s disease. Cell Stem Cell. 2015;17:397\u2013411. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590915003562.","journal-title":"Cell Stem Cell."},{"key":"1549_CR72","doi-asserted-by":"crossref","unstructured":"Zeng P-Y, Tsai Y-H, Lee C-L, Ma Y-K, Kuo T-H. Minimal influence of estrous cycle on studies of female mouse behaviors. Front Mol Neurosci. 2023;16. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2023.1146109\/full","DOI":"10.3389\/fnmol.2023.1146109"},{"key":"1549_CR73","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.cub.2023.02.035","volume":"33","author":"DR Levy","year":"2023","unstructured":"Levy DR, Hunter N, Lin S, Robinson EM, Gillis W, Conlin EB, et al. Mouse spontaneous behavior reflects individual variation rather than estrous state. Curr Biol. 2023;33:1358-1364.e4. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960982223001756.","journal-title":"Curr Biol."},{"key":"1549_CR74","doi-asserted-by":"crossref","unstructured":"Broestl L, Worden K, Moreno AJ, Davis EJ, Wang D, Garay B, et al. Ovarian cycle stages modulate Alzheimer-related cognitive and brain network alterations in female mice. eneuro. 2018;5:ENEURO.0132\u201317.2018. Available from: https:\/\/www.eneuro.org\/lookup\/doi\/10.1523\/ENEURO.0132-17.2018","DOI":"10.1523\/ENEURO.0132-17.2018"},{"key":"1549_CR75","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1601-183X.2009.00476.x","volume":"8","author":"D Gangitano","year":"2009","unstructured":"Gangitano D, Salas R, Teng Y, Perez E, De Biasi M. Progesterone modulation of \u03b15 nAChR subunits influences anxiety-related behavior during estrus cycle. Genes, Brain Behav. 2009;8:398\u2013406. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-183X.2009.00476.x.","journal-title":"Genes, Brain Behav."},{"key":"1549_CR76","doi-asserted-by":"publisher","first-page":"101010","DOI":"10.1016\/j.yfrne.2022.101010","volume":"66","author":"M Kundakovic","year":"2022","unstructured":"Kundakovic M, Rocks D. Sex hormone fluctuation and increased female risk for depression and anxiety disorders: From clinical evidence to molecular mechanisms. Front Neuroendocrinol. 2022;66:101010. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091302222000334.","journal-title":"Front Neuroendocrinol."},{"key":"1549_CR77","doi-asserted-by":"crossref","unstructured":"Lovick TA, Zangrossi H. Effect of Estrous Cycle on Behavior of Females in Rodent Tests of Anxiety. Front Psychiatry. 2021;12. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.711065\/full","DOI":"10.3389\/fpsyt.2021.711065"},{"key":"1549_CR78","doi-asserted-by":"crossref","unstructured":"Zhao W, Li Q, Ma Y, Wang Z, Fan B, Zhai X, et al. Behaviors Related to Psychiatric Disorders and Pain Perception in C57BL\/6J Mice During Different Phases of Estrous Cycle. Front Neurosci. 2021;15. . Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.650793\/full","DOI":"10.3389\/fnins.2021.650793"},{"key":"1549_CR79","doi-asserted-by":"crossref","unstructured":"Francois M, Canal Delgado I, Shargorodsky N, Leu C-S, Zeltser L. Assessing the effects of stress on feeding behaviors in laboratory mice. Elife. 2022;11. . Available from: https:\/\/elifesciences.org\/articles\/70271","DOI":"10.7554\/eLife.70271"},{"key":"1549_CR80","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1093\/humrep\/der183","volume":"26","author":"JE Hirshfeld-Cytron","year":"2011","unstructured":"Hirshfeld-Cytron JE, Duncan FE, Xu M, Jozefik JK, Shea LD, Woodruff TK. Animal age, weight and estrus cycle stage impact the quality of in vitro grown follicles. Hum Reprod. 2011;26:2473\u201385. Available from: https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/der183.","journal-title":"Hum Reprod."},{"key":"1549_CR81","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0031-9384(01)00599-6","volume":"74","author":"GC Parker","year":"2001","unstructured":"Parker GC, McKee ME, Bishop C, Coscina DV. Whole-body metabolism varies across the estrous cycle in Sprague-Dawley rats. Physiol Behav. 2001;74:399\u2013403. . Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938401005996.","journal-title":"Physiol Behav."}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01549-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T18:03:58Z","timestamp":1732644238000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01549-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1549"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01549-x","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}